Molinari Michele, Kaltenmeier Christof, Samra Patrick-Bou, Liu Hao, Wessel Charles, Lou Klem Mary, Dharmayan Stalin, Emmanuel Bishoy, Al Harakeh Hasan, Tohme Samer, Geller David, Tevar Amit, Hughes Christopher B, Humar Abhinav, Bataller Ramon, Behari Jaideep
From the Department of Surgery, Division of Transplant Surgery, University of Pittsburgh, Pittsburgh, PA.
Department of Surgery, Division of General Surgery, Johns Hopkins University, Baltimore, MD.
Ann Surg Open. 2021 May 3;2(2):e065. doi: 10.1097/AS9.0000000000000065. eCollection 2021 Jun.
To systematically review and compare the overall (OS) and disease-free (DFS) survival after hepatic resections for hepatocellular carcinoma (HCC) of patients with nonalcoholic fatty liver disease (NAFLD) versus other risk factors.
Different clinical and tumor characteristics are associated with HCC in the setting of NAFLD in comparison to other risk factors. It is still unclear whether these differences impact patient survival after radical hepatectomies.
Randomized controlled trials and observational studies published in the English literature between July 1980 and June 2020 were searched using multiple databases. Patients' baseline characteristics and the hazard ratios (HRs) of the OS and DFS were extracted and meta-analyses were performed.
Fifteen retrospective cohort studies with a total of 7226 patients were included. Among them, 1412 patients (19.5%) had NAFLD and 5814 (80.4%) had other risk factors (eg, viral hepatitis B or C, alcoholic cirrhosis, or cryptogenic cirrhosis). Summary statistics showed that patients with NAFLD had better DFS (HR = 0.81; 95% CI: 0.70-0.94; = 0.006) and OS (HR = 0.78; 95% CI: 0.67-0.90; = 0.001) than the control group. Subgroups analyses also indicated that the OS favored NAFLD patients versus patients with viral hepatitis B or C (HR = 0.80; 95% CI: 0.67-0.96; = 0.017) or alcoholic and cryptogenic cirrhosis (HR = 0.68; 95% CI: 0.47-1.0; = 0.05).
After hepatic resections for HCC, NAFLD patients have better DFS and OS than patients with other risk factors. Subgroup analysis and meta-regression suggested that the survival advantage of NAFLD patients was more pronounced in studies published after 2015 and from Asian centers.
系统评价并比较非酒精性脂肪性肝病(NAFLD)患者与其他风险因素患者肝细胞癌(HCC)肝切除术后的总生存期(OS)和无病生存期(DFS)。
与其他风险因素相比,NAFLD背景下的HCC具有不同的临床和肿瘤特征。目前尚不清楚这些差异是否会影响根治性肝切除术后患者的生存。
使用多个数据库检索1980年7月至2020年6月期间发表在英文文献中的随机对照试验和观察性研究。提取患者的基线特征以及OS和DFS的风险比(HRs),并进行荟萃分析。
纳入15项回顾性队列研究,共7226例患者。其中,1412例患者(19.5%)患有NAFLD,5814例(80.4%)有其他风险因素(如乙型或丙型病毒性肝炎、酒精性肝硬化或隐源性肝硬化)。汇总统计显示,NAFLD患者的DFS(HR = 0.81;95%CI:0.70 - 0.94;P = 0.006)和OS(HR = 0.78;95%CI:0.67 - 0.90;P = 0.001)均优于对照组。亚组分析还表明,与乙型或丙型病毒性肝炎患者(HR = 0.80;95%CI:0.67 - 0.96;P = 0.017)或酒精性和隐源性肝硬化患者(HR = 0.68;95%CI:0.47 - 1.0;P = 0.05)相比,OS更有利于NAFLD患者。
HCC肝切除术后,NAFLD患者的DFS和OS优于其他风险因素患者。亚组分析和荟萃回归表明,2015年后发表的研究以及来自亚洲中心的研究中,NAFLD患者的生存优势更为明显。